Cristina Guarducci, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Estrogen | 10 | 2024 | 2210 | 0.910 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2024 | 656 | 0.720 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2024 | 995 | 0.630 |
Why?
|
Cell Cycle | 1 | 2024 | 2934 | 0.520 |
Why?
|
Cyclin-Dependent Kinase 4 | 4 | 2024 | 556 | 0.480 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21025 | 0.450 |
Why?
|
Protein Kinase Inhibitors | 3 | 2024 | 5643 | 0.410 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2024 | 5253 | 0.410 |
Why?
|
Receptor, erbB-2 | 7 | 2024 | 2554 | 0.380 |
Why?
|
Piperazines | 4 | 2024 | 2525 | 0.350 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2021 | 346 | 0.330 |
Why?
|
Pyridines | 4 | 2024 | 2879 | 0.320 |
Why?
|
Apoptosis | 2 | 2024 | 9501 | 0.320 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2016 | 1529 | 0.210 |
Why?
|
Signal Transduction | 3 | 2024 | 23376 | 0.200 |
Why?
|
Carcinoma, Lobular | 1 | 2022 | 489 | 0.150 |
Why?
|
Genes, Retinoblastoma | 1 | 2018 | 125 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2024 | 3584 | 0.130 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2022 | 1096 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2488 | 0.120 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 938 | 0.120 |
Why?
|
Retinoblastoma Protein | 1 | 2016 | 670 | 0.110 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16939 | 0.100 |
Why?
|
Estradiol | 2 | 2016 | 1932 | 0.100 |
Why?
|
Cell Proliferation | 1 | 2024 | 10446 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8515 | 0.080 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13630 | 0.060 |
Why?
|
Tamoxifen | 2 | 2022 | 963 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11712 | 0.050 |
Why?
|
Female | 13 | 2024 | 391270 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1135 | 0.040 |
Why?
|
Antigen Presentation | 1 | 2023 | 1254 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 979 | 0.040 |
Why?
|
E2F2 Transcription Factor | 1 | 2016 | 35 | 0.040 |
Why?
|
Mice | 1 | 2024 | 81208 | 0.040 |
Why?
|
Cell Count | 1 | 2021 | 1835 | 0.030 |
Why?
|
Humans | 13 | 2024 | 760621 | 0.030 |
Why?
|
Postmenopause | 2 | 2016 | 2509 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2016 | 178 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2021 | 1130 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 2016 | 79 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 165 | 0.030 |
Why?
|
Biomarkers, Pharmacological | 1 | 2016 | 162 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2326 | 0.030 |
Why?
|
Animals | 2 | 2024 | 167963 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2024 | 2864 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2016 | 695 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2873 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6131 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1889 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9411 | 0.020 |
Why?
|
Aromatase Inhibitors | 1 | 2015 | 511 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2938 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3844 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3568 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 29658 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2821 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6828 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4902 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13502 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10182 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11152 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 65017 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12427 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58995 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 220352 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29932 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 58741 | 0.010 |
Why?
|
Aged | 1 | 2018 | 169152 | 0.000 |
Why?
|
Adult | 1 | 2018 | 219994 | 0.000 |
Why?
|